News

SEC Filings

Document Details

Form
Filing Date
April 14, 2020
Document Date
March 11, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
LIEU HSIAO D

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com